Skip to main content

BioSystems International Installs Spotfire s DecisionSite Software

NEW YORK, Dec. 13 (GenomeWeb News) - BioSystems International has purchased Spotfire's flagship DecisionSite software, the company said today. 

 

BSI has deployed DecisionSite to investigate and analyze several classes of biomarkers, including stratification markers that predict the likelihood of a drug response; efficacy biomarkers that predict a clinical outcome; screening markers for the early detection of diseases; and prognostic markers to predict the likely course of the disease, Spotfire said.

 

Financial terms of the deal were not disclosed.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.